These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 33439112)
1. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020. Parham DM; Giannikopoulos P Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112 [TBL] [Abstract][Full Text] [Related]
2. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Folpe AL; McKenney JK; Bridge JA; Weiss SW Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574 [TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry. Dehner CA; Rudzinski ER; Davis JL Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061 [TBL] [Abstract][Full Text] [Related]
6. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review. Kohashi K; Kinoshita I; Oda Y Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473 [TBL] [Abstract][Full Text] [Related]
7. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732 [TBL] [Abstract][Full Text] [Related]
8. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas. Ruymann FB; Grovas AC Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991 [TBL] [Abstract][Full Text] [Related]
9. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms. Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298 [TBL] [Abstract][Full Text] [Related]
10. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH; Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526 [TBL] [Abstract][Full Text] [Related]
11. An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma. Fan R; Parham DM; Wang LL Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261 [TBL] [Abstract][Full Text] [Related]
13. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature. Vadgama B; Sebire NJ; Malone M; Ramsay AD Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934 [TBL] [Abstract][Full Text] [Related]
15. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature]. Zhu L; Wang J Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445 [TBL] [Abstract][Full Text] [Related]
16. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Parham DM Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document. Panda SP; Chinnaswamy G; Vora T; Prasad M; Bansal D; Kapoor G; Radhakrishnan V; Agarwala S; Laskar S; Arora B; Kaur T; Rath GK; Bakhshi S Indian J Pediatr; 2017 May; 84(5):393-402. PubMed ID: 28378141 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience. Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515 [TBL] [Abstract][Full Text] [Related]
19. The current landscape of rhabdomyosarcomas: an update. Leiner J; Le Loarer F Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361 [TBL] [Abstract][Full Text] [Related]
20. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials. Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]